Pancreatitis Trial, Recruiting NCT07700992 Sponsor: Università Vita-Salute San Raffaele Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07700992
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older at the time their blood plasma sample was collected.
  • People who have been identified as having a higher-than-average risk of developing a specific type of pancreatic cancer (called pancreatic ductal adenocarcinoma) because of a family history of pancreatic cancer or an inherited condition linked to it.
  • People who have been identified as having a higher-than-average risk of developing this type of pancreatic cancer because they have one or more fluid-filled cysts in the pancreas of a specific type (called mucinous pancreatic cystic lesions).
  • People for whom stored blood plasma samples are available, collected during routine medical care and held in a hospital or institutional sample bank.
  • People for whom sufficient medical and personal health records are available at the institution to meet the study's objectives.
  • People who have previously given consent for their stored samples and health data to be used for research purposes.

Who may not be able to join:

  • Cases where the stored plasma samples are unavailable, or are not of sufficient quality or quantity for laboratory testing.
  • Cases where the necessary medical records are not available for grouping participants or assessing health outcomes.
  • People who had pancreatic surgery or an interventional procedure on the pancreas before their plasma sample was collected.
  • People who had an active cancer (other than a common type of non-dangerous skin cancer) at the time their sample was collected.
  • Cases where samples were not collected as part of routine clinical care, or do not meet the institution's rules for sample banking and data protection.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alessandro Mannucci, MD, Università Vita-Salute San Raffaele

Phone: 0226437262

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Università Vita-Salute San Raffaele
Registry
ClinicalTrials.gov
Start date
3 June 2026
Est. completion
31 December 2031

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Sensitivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov